Cervical Cancer News and Research

RSS

Cancer is a disease in which cells in the body grow out of control. Cancer is always named for the part of the body where it starts, even if it spreads to other body parts later. When cancer starts in the cervix, it is called cervical cancer. The cervix is the lower, narrow end of the uterus. Also known as the womb, the uterus is where a baby grows when a woman is pregnant. The cervix connects the upper part of the uterus to the vagina (birth canal).

Cervical cancer is highly preventable in most Western countries because screening tests and a vaccine to prevent HPV infections are available. When cervical cancer is found early, it is highly treatable and associated with long survival and good quality of life.

New research explores how genetic factors may be linked to low cervical cancer rates in Western Asia

New research provides an insight into why cervical cancer is less common in certain regions of the world even though they may have limited screening and fewer or no prevention programs.

10 Apr 2017

Two in every five people in the US carry Human Papilloma Virus

Latest estimates of the prevalence of the human papilloma virus (HPV) in the US were published this month. Among the adult population, genital HPV was identified in 45% of men and 40% of women. The prevalence of oral HPV was 11.5% among men and 3.3% among women.

7 Apr 2017

Number of HIV-positive cancer patients in the U.S. projected to decrease through 2030

As the population of people living with HIV in the United States ages, the burden of cancer for these patients is expected to shift away from cancers linked to AIDS and toward malignancies that affect the general population, according to a new study led by a University of North Carolina at Chapel Hill researcher.

5 Apr 2017

New antibody test can detect person’s risk for developing HPV-related cancer of the oropharynx

Cancer of the oropharynx has become increasingly common: In the United States alone, the number of newly diagnosed cases has tripled over the past three decades. About 70 percent of these tumors are caused by infection with human papillomavirus (HPV) type 16.

3 Apr 2017

Study provides new understanding of molecular mechanisms of HPV-induced tumors

The incidence of human papillomavirus (HPV)-associated (HPV+) head and neck squamous cell carcinoma (HNSCC) of the oropharynx has dramatically increased over the last decade and is now more frequently diagnosed than uterine cervical cancer in the United States.

31 Mar 2017

Fighting colorectal cancer

Colorectal cancer is a combined term to describe the malignant tumors that occur in the large intestine; the colon being the upper part of the large intestine and the rectum being the lowest part of the large intestine.

31 Mar 2017

Researchers develop new method that uses gene editing to find cancer's weak spots

Genetic mutations that cause cancer also weaken cancer cells, creating an opportunity for researchers to develop drugs that will selectively kill them, while sparing normal cells.

20 Mar 2017

ASCO issues first clinical practice guideline on HPV vaccination for cervical cancer prevention

The American Society of Clinical Oncology (ASCO) today issued a clinical practice guideline on human papillomavirus (HPV) vaccination for the prevention of cervical cancer.

17 Mar 2017

Research reveals reasons for adolescents not getting vaccinated against HPV

Concern about sexual activity is declining as a reason parents do not get their daughters the human papillomavirus (HPV) vaccine, according to a research study presented today at the Society of Gynecologic Oncology’s 2017 Annual Meeting on Women’s Cancer.

16 Mar 2017

CPRIT awards $1.5 million grant to reduce burden of cervical cancer in West Texas

Navkiran Shokar, M.A., M.P.H, M.D., has received nearly $1.5 million from the Cancer Prevention and Research Institute of Texas to reduce the burden of cervical cancer in West Texas.

8 Mar 2017

Many women do not receive guideline-based care for cervical cancer, study finds

Women with locally advanced cervical cancer whose treatment follows national guidelines for care have better survival, regardless of race, ethnicity or stage of cancer.

2 Mar 2017

Scientists to develop 'next generation' device that could help predict risk of preterm birth

A NEW ‘next generation’ device which could help doctors reliably predict the risk of preterm birth is to be developed by Sheffield Teaching Hospitals NHS Foundation Trust and the University of Sheffield thanks to funding from the National Institute for Health Research (NIHR).

1 Mar 2017

New model of cervical cancer care reduces delay between diagnosis and treatment

Cervical cancer is the leading cause of cancer deaths for women low- and middle-income countries, including Botswana, where 75 percent of cervical cancer patients suffer from advanced forms of the disease.

21 Feb 2017

Study discovers how gut bacteria interacts with microRNAs to promote colon cancer growth

Gut microbes can influence the growth of colon cancer, though little is known about how they trigger the disease.

14 Feb 2017

Cervical cancer mortality rates higher than previously thought, study reveals

A new analysis reveals that for most women, the risk of dying from cervical cancer is higher than previously thought. Unlike prior estimates that also included women who had undergone a hysterectomy and were therefore no longer at risk, this analysis only included women with a cervix.

24 Jan 2017

Cervical cancer death rate among older and black women higher than previously thought

A woman's risk of dying of cervical cancer is higher than long believed, particularly among older and black women, new Johns Hopkins Bloomberg School of Public Health-led research suggests.

23 Jan 2017

Researchers identify new subgroup of cervical cancers with different genetic features

A team of University of South Carolina scientists led by Carolyn Banister and Phillip Buckhaults has identified a new subtype of cervical cancer that, like most cervical cancers, is triggered by human papillomavirus (HPV) but whose growth is not directed by the virus, suggesting that therapy targeting these tumors' distinct genomic pathways may improve patient outcomes over standard treatment.

11 Jan 2017

ESCMID grant helps young investigators to study microorganisms, find better approaches to treat infectious diseases

The European Society of Clinical Microbiology and Infectious Diseases through its annual grant programme helps young investigators pursue ground-breaking research to advance our understanding of microorganisms and find better approaches to diagnose, prevent and treat infectious diseases.

5 Jan 2017

Women with advanced kidney disease not receiving recommended breast or cervical cancer screening

A new study indicates that many women with advanced kidney disease are not receiving recommended breast or cervical cancer screening, even though they face a higher risk of developing cancer than women in the general population.

30 Dec 2016

Scientists uncover new class of compounds that could help target cancer cells

Scientists from Trinity College Dublin have uncovered a new class of compounds - glyconaphthalimides - that can be used to target cancer cells with greater specificity than current options allow.

7 Dec 2016